Current trials in DMD
The table below lists all DMD trials registered or updated on clinicaltrials.gov in the last 1000 days. Because it links directly to clinicaltrials.gov it is automatically updated whenever the information on clinicaltrials.gov changes.
Please note that TREAT-NMD can take no responsibility for the accuracy of the information below, which is pulled directly from clinicaltrials.gov.
Trials for DMD listed on clinicaltrials.gov
- The Effect of Telerehabilitation of Patients With Duchenne Muscular Dystrophy
- Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)
- Heart Rate Variability in Individuals With Duchenne Muscular Dystrophy
- An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy
- Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)
- The Effects of Trunk Exercises on Upper Extremity and Respiratory Functions in DMD
- Brain Involvement in Dystrophinopathies Part 2
- A Phase 3 Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids, in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
- A Gene Delivery Study to Evaluate the Safety of and Expression From SRP-9001 in Duchenne Muscular Dystrophy (DMD)
- Heart Rate Variability in Duchenne Muscular Dystrophy During Computer Task
- A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults
- A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD）
- Brain Involvement in Dystrophinopathies (WP5) Part 1
- Sleep Intervention in Young Boys With Duchenne Muscular Dystrophy
- Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
- Open-label Extension of the HOPE-2 Trial
- Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy
- Digestive Events in Duchenne Muscular Dystrophy Patients
- A Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids, in Subjects With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
- Effect of Foot Structure and Foot and Body Posture on Gait and Balance in Duchenne Muscular Dystrophy
